Femasys FEMY
NASDAQ FEMY
$2.16 +0.08 (+3.59%)
As of: Sep 30, 2026 · 2:29 PM EDT

Femasys (FEMY) Non-Current Debt (2020)

Updated

Femasys (FEMY) posted Non-Current Debt of $182,490 for Q4 2020.

Analysis

Femasys (FEMY) Non-Current Debt (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 39.18 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn 29.60 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 25.15 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn -
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 25.62 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 14.19 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 10.92 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 598.70 Mn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 13.51 Bn
10 Femasys 6.32 Mn -14.34 Mn 189,391.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 182,490.00
API Access

Femasys Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=FEMY&period=max&api_key=YOUR_API_KEY